Literature DB >> 11395362

Pten, a protean tumor suppressor.

G L Mutter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11395362      PMCID： PMC1891981          DOI： 10.1016/S0002-9440(10)64656-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  47 in total

1.  Changes in endometrial PTEN expression throughout the human menstrual cycle.

Authors:  G L Mutter; M C Lin; J T Fitzgerald; J B Kum; C Eng
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

2.  Gatekeeper for endometrium: the PTEN tumor suppressor gene.

Authors:  I U Ali
Journal:  J Natl Cancer Inst       Date:  2000-06-07       Impact factor: 13.506

3.  10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer.

Authors:  M A Rubin; A Gerstein; K Reid; D G Bostwick; L Cheng; R Parsons; N Papadopoulos
Journal:  Hum Pathol       Date:  2000-04       Impact factor: 3.466

4.  PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases.

Authors:  E Bussaglia; E del Rio; X Matias-Guiu; J Prat
Journal:  Hum Pathol       Date:  2000-03       Impact factor: 3.466

5.  PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.

Authors:  L P Weng; W M Smith; P L Dahia; U Ziebold; E Gil; J A Lees; C Eng
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

6.  Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.

Authors:  G L Mutter; M C Lin; J T Fitzgerald; J B Kum; J P Baak; J A Lees; L P Weng; C Eng
Journal:  J Natl Cancer Inst       Date:  2000-06-07       Impact factor: 13.506

7.  High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

Authors:  V Stambolic; M S Tsao; D Macpherson; A Suzuki; W B Chapman; T W Mak
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

8.  Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases.

Authors:  J Liliental; S Y Moon; R Lesche; R Mamillapalli; D Li; Y Zheng; H Sun; H Wu
Journal:  Curr Biol       Date:  2000-04-06       Impact factor: 10.834

9.  Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.

Authors:  A Perren; L P Weng; A H Boag; U Ziebold; K Thakore; P L Dahia; P Komminoth; J A Lees; L M Mulligan; G L Mutter; C Eng
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

10.  Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors.

Authors:  O Gimm; A Perren; L P Weng; D J Marsh; J J Yeh; U Ziebold; E Gil; R Hinze; L Delbridge; J A Lees; G L Mutter; B G Robinson; P Komminoth; H Dralle; C Eng
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307
View more
  28 in total

Review 1.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.

Authors:  Nicolas M Monte; Kaitlyn A Webster; Donna Neuberg; Gregory R Dressler; George L Mutter
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

Review 3.  Regulation of gene expression in the intestinal epithelium.

Authors:  Camilla A Richmond; David T Breault
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

4.  EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells.

Authors:  Tian Li; Yuebo Yang; Xiaomao Li; Chengfang Xu; Lirong Meng
Journal:  Mol Cell Biochem       Date:  2011-09-28       Impact factor: 3.396

5.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

6.  Primary squamous cell carcinoma of the endometrium unrelated to human papilloma virus: a molecular study.

Authors:  Giovanna Giordano; Silvia Pizzi; Cinzia Azzoni; Lorena Bottarelli; Tiziana D'Adda
Journal:  Pathol Oncol Res       Date:  2013-02-21       Impact factor: 3.201

7.  Augmented BMP signaling in the neural crest inhibits nasal cartilage morphogenesis by inducing p53-mediated apoptosis.

Authors:  Satoru Hayano; Yoshihiro Komatsu; Haichun Pan; Yuji Mishina
Journal:  Development       Date:  2015-03-05       Impact factor: 6.868

8.  Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma.

Authors:  Yingmei Wang; Da Yang; David Cogdell; Limei Hu; Fengxia Xue; Russell Broaddus; Wei Zhang
Journal:  Technol Cancer Res Treat       Date:  2010-04

9.  Genetics of endometrial cancers.

Authors:  Tsuyoshi Okuda; Akihiko Sekizawa; Yuditiya Purwosunu; Masaaki Nagatsuka; Miki Morioka; Masaki Hayashi; Takashi Okai
Journal:  Obstet Gynecol Int       Date:  2010-04-08

10.  Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.

Authors:  Ming-Chieh Lin; Kyla A Burkholder; Akila N Viswanathan; Donna Neuberg; George L Mutter
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.